FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

704314009: Tofacitinib citrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3012850018 Tofacitinib citrate en Synonym Active Entire term case insensitive SNOMED CT core module
3012865017 Tofacitinib citrate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tofacitinib citrate Is a Tofacitinib false Inferred relationship Existential restriction modifier
Tofacitinib citrate Has disposition Janus kinase inhibitor true Inferred relationship Existential restriction modifier
Tofacitinib citrate Is modification of Tofacitinib true Inferred relationship Existential restriction modifier
Tofacitinib citrate Is a Substance with Janus kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Tofacitinib citrate Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Tofacitinib citrate Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Tofacitinib citrate Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Tofacitinib citrate Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Tofacitinib citrate Is a Nitrile true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely tofacitinib citrate 5 milligram/1 each conventional release oral tablet Has active ingredient False Tofacitinib citrate Inferred relationship Existential restriction modifier
Product containing precisely tofacitinib citrate 5 milligram/1 each conventional release oral tablet Has active ingredient False Tofacitinib citrate Inferred relationship Existential restriction modifier 1
Product containing precisely tofacitinib citrate 5 milligram/1 each conventional release oral tablet Has basis of strength substance False Tofacitinib citrate Inferred relationship Existential restriction modifier 1
Product containing precisely tofacitinib citrate 5 milligram/1 each conventional release oral tablet Has precise active ingredient False Tofacitinib citrate Inferred relationship Existential restriction modifier 1
Product containing precisely tofacitinib (as tofacitinib citrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier 1
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier 1
Tofacitinib 1mg/ml oral solution sugar free Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 1mg/ml oral solution sugar free 240 ml Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Xeljanz 1mg/ml oral solution (Pfizer Ltd) Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Xeljanz 1mg/ml oral solution (Pfizer Ltd) 240 ml Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 5mg tablets Has specific active ingredient False Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 5mg tablets Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 11mg modified-release tablets Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Xeljanz 11mg modified-release tablets (Pfizer Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Xeljanz 11mg modified-release tablets (Pfizer Ltd) Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 11mg modified-release tablets 28 tablet Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 5mg tablets (Special Order) Has active ingredient False Tofacitinib citrate Inferred relationship Existential restriction modifier
Xeljanz 5mg tablets (Pfizer Ltd) Has active ingredient False Tofacitinib citrate Inferred relationship Existential restriction modifier
Product containing precisely tofacitinib citrate 5 milligram/1 each conventional release oral tablet Has specific active ingredient False Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 5mg tablets (Special Order) Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 5mg tablets 1 tablet Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 5mg tablets 56 tablet Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Xeljanz 5mg tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 5mg tablets (Special Order) 1 tablet Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Xeljanz 5mg tablets (Pfizer Ltd) Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 10mg tablets 56 tablet Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Tofacitinib 10mg tablets Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Tofacitinib citrate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start